Cardiovascular & Hematological Disorders-Drug Targets

(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders)


Garry X. Shen  
University of Manitoba
Winnipeg, MB


Become EABM
Become Reviewer

Abstract Ahead of Print

Efficacy of Cangrelor as bridging therapy post PCI

Abdul Khan, Ghulam Murtaza*, Muhmammad Khalid, Mathew Finniss and Thomas Helton

Stroke following successful PTMC in a patient with severe mitral stenosis: A case report and presenting a simple stepwise approach to PTMC-related stroke

Mohammad Hasan Namazi, Isa Khaheshi*, Alireza Kaveh, Fatemeh Taherian, Mohammadreza Naderian and Mohammadreza Tabary

Assessment of admission time cell blood count (CBC) parameters in predicting post- primary percutaneous coronary intervention TIMI frame count in patients with ST-segment elevation myocardial infarction

Hossein Vakili, Isa Khaheshi*, Amirsina Sharifi, Negin Nickdoost, Mohammad Hasan Namazi, Morteza Safi , Habibollah Saadat, Saeed Alipour Parsa, Mohammad Ali Akbarzadeh, Mohammadreza Naderian, Negin Yousefi, Mahin Shirazi and Mohammadreza Tabary

Co-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome

Chara Giatra, Alexandros G. Sykaras, Fotis Constantinou, Victoria Gennimata, Dimitrios Sampaziotis, Eleni Geladari, Dimitris Kounatidis and Natalia G. Vallianou*